Hirotaka Asakura

753 total citations
48 papers, 558 citations indexed

About

Hirotaka Asakura is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Hirotaka Asakura has authored 48 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 11 papers in Urology. Recurrent topics in Hirotaka Asakura's work include Bladder and Urothelial Cancer Treatments (8 papers), Kidney Stones and Urolithiasis Treatments (6 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Hirotaka Asakura is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Kidney Stones and Urolithiasis Treatments (6 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Hirotaka Asakura collaborates with scholars based in Japan, United States and Greece. Hirotaka Asakura's co-authors include Masaru Murai, Jun Nakashima, Takashi Ohigashi, Mototsugu Oya, Ken Nakagawa, Masaaki Tachibana, Akira Miyajima, Eiji Kikuchi, Kent Kanao and Hitoshi Yanaihara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and The Journal of Urology.

In The Last Decade

Hirotaka Asakura

40 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirotaka Asakura Japan 13 282 130 108 107 95 48 558
Dimitrios Delakas Greece 13 287 1.0× 212 1.6× 159 1.5× 100 0.9× 69 0.7× 24 559
Hulin Li China 12 380 1.3× 75 0.6× 116 1.1× 164 1.5× 71 0.7× 36 610
Qing Jiang China 11 232 0.8× 153 1.2× 73 0.7× 152 1.4× 59 0.6× 44 555
É. Chabannes France 14 283 1.0× 285 2.2× 223 2.1× 142 1.3× 51 0.5× 47 696
Yi Shao China 13 413 1.5× 52 0.4× 133 1.2× 120 1.1× 35 0.4× 39 630
Chun Il Kim South Korea 11 239 0.8× 93 0.7× 66 0.6× 30 0.3× 60 0.6× 45 420
Yukihiko Ohishi Japan 11 180 0.6× 158 1.2× 107 1.0× 26 0.2× 72 0.8× 51 448
I. Karyotis Greece 10 281 1.0× 103 0.8× 137 1.3× 106 1.0× 42 0.4× 14 439
Clara Cerrato Italy 12 344 1.2× 121 0.9× 167 1.5× 26 0.2× 60 0.6× 70 523
R. Nagel Germany 13 265 0.9× 149 1.1× 103 1.0× 51 0.5× 69 0.7× 71 510

Countries citing papers authored by Hirotaka Asakura

Since Specialization
Citations

This map shows the geographic impact of Hirotaka Asakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirotaka Asakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirotaka Asakura more than expected).

Fields of papers citing papers by Hirotaka Asakura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirotaka Asakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirotaka Asakura. The network helps show where Hirotaka Asakura may publish in the future.

Co-authorship network of co-authors of Hirotaka Asakura

This figure shows the co-authorship network connecting the top 25 collaborators of Hirotaka Asakura. A scholar is included among the top collaborators of Hirotaka Asakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirotaka Asakura. Hirotaka Asakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shinojima, Toshiaki, et al.. (2025). Fatal Tumor Lysis Syndrome Induced by Pembrolizumab in Advanced Renal Pelvis Cancer. IJU Case Reports. 9(1). e70097–e70097.
2.
3.
4.
Kikuchi, Eiji, Koichiro Ogihara, Keisuke Shigeta, et al.. (2021). Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer. Annals of Surgical Oncology. 28(9). 5349–5359. 4 indexed citations
5.
Kikuchi, Eiji, Keisuke Shigeta, Koichiro Ogihara, et al.. (2021). Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer. International Journal of Clinical Oncology. 26(11). 2094–2103. 6 indexed citations
6.
Zhang, Zhen, Atsushi Sasaki, Masanori Yasuda, et al.. (2019). Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity. The Journal of Steroid Biochemistry and Molecular Biology. 191. 105361–105361. 14 indexed citations
7.
Yanaihara, Hitoshi, et al.. (2018). Emphysematous pyelonephritis with successful renal preservation using open drainage surgery: A case report. Urology Case Reports. 17. 76–78. 1 indexed citations
8.
Tasaki, Shinsuke, Akio Horiguchi, Takako Asano, et al.. (2017). Docosahexaenoic acid inhibits the phosphorylation of STAT3 and the growth and invasion of renal cancer cells. Experimental and Therapeutic Medicine. 14(2). 1146–1152. 17 indexed citations
9.
Ogihara, Koichiro, Eiji Kikuchi, Kazuyuki Yuge, et al.. (2015). Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients. Annals of Surgical Oncology. 23(5). 1752–1759. 21 indexed citations
10.
Yanaihara, Hitoshi, et al.. (2015). Laparoscopic Non-clamping Tumor Enucleation of Renal Hilum Schwannoma in a Single Kidney: A Case Report. SHILAP Revista de lepidopterología. 3(6). 211–214. 5 indexed citations
11.
Yanaihara, Hitoshi, et al.. (2011). [Clinical assessment of perioperative course of patients undergoing laparoscopic nephrectomy or adrenalectomy without perioperative bowel management].. PubMed. 57(8). 407–9. 3 indexed citations
12.
Ohta, Shoichiro, et al.. (2011). Possibility of molecular targeting therapy for the treatment of cancer of unknown primary origin by analysis of intracellular signaling molecules. Experimental and Therapeutic Medicine. 3(3). 547–549. 4 indexed citations
13.
Watada, Susumu, et al.. (2010). A case of resectable pancreatic metastasis from renal cell carcinoma without FDG accumulation on PET. Suizo. 25(1). 67–72. 2 indexed citations
14.
Oya, Mototsugu, Hirotaka Asakura, Ryuichi Mizuno, Ken Marumo, & Masaru Murai. (2005). Repeated regression of pulmonary metastases from renal cell carcinoma after treatment using different interferon-alpha preparations. Biomedical Research. 26(3). 135–137. 3 indexed citations
15.
Ito, Keiichi, Jun Nakashima, Makio Mukai, et al.. (2003). Prognostic Implication of Microvascular Invasion in Biochemical Failure in Patients Treated with Radical Prostatectomy. Urologia Internationalis. 70(4). 297–302. 33 indexed citations
16.
Asakura, Hirotaka & Masaru Murai. (2003). [Psychogenic frequency-urgency syndrome, difficulty on urination].. PubMed. 567–70. 1 indexed citations
17.
Marumo, Ken, Yutaka Horiguchi, Ken Nakagawa, et al.. (2003). Incidence and growth pattern of simple cysts of the kidney in patients with asymptomatic microscopic hematuria. International Journal of Urology. 10(2). 63–67. 38 indexed citations
18.
Asakura, Hirotaka, Jeremy Selengut, William H. Orme‐Johnson, & Stephen P. Dretler. (1998). THE EFFECT OF CALPROTECTIN ON THE NUCLEATION AND GROWTH OF STRUVITE CRYSTALS AS ASSAYED BY LIGHT MICROSCOPY IN REAL-TIME. The Journal of Urology. 1384–1389. 1 indexed citations
19.
Baba, Shiro, Takeshi Masuda, Hirotaka Asakura, et al.. (1989). CLINICAL EXPERIENCE WITH URETEROMAT IN TRANSURETHRAL URETERORENOSCOPY. The Japanese Journal of Urology. 80(8). 1211–1217. 3 indexed citations
20.
Miyairi, Mamoru, et al.. (1979). Kinetic and electron microscopic study on relationship between the collecting lymphatics and the surrounding blood vessels in rat mesentery.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios Delakas Breakdown of academic impact, for papers by Hulin Li Breakdown of academic impact, for papers by Qing Jiang Breakdown of academic impact, for papers by É. Chabannes Breakdown of academic impact, for papers by Yi Shao Breakdown of academic impact, for papers by Chun Il Kim Breakdown of academic impact, for papers by Yukihiko Ohishi Breakdown of academic impact, for papers by I. Karyotis Breakdown of academic impact, for papers by Clara Cerrato Breakdown of academic impact, for papers by R. Nagel
Rankless by CCL
2026